Innovation Incubator | Kisaco Research

This session provides the unique opportunity to listen to, and engage with, some of the most innovative AI Drug Discovery and Development start-ups globally. Focusing exclusively on early-stage funding, six startups picked by our esteemed selection committee will take to the stage in front of 100+ potential partners. Through a series of rapid-fire presentations, these pioneers will demonstrate their vision of the future of drug discovery, and how their product, technology, or service fits into it.

Speaker(s): 
Judges

Author:

Parthiban Rajasekaran

Innovation Lead
Sanofi

Parthiban Rajasekaran

Innovation Lead
Sanofi

Author:

Uli Stilz

Corporate Vice President, R&ED External Innovation Partners, External & Exploratory Innovation
Novo Nordisk

Uli Stilz

Corporate Vice President, R&ED External Innovation Partners, External & Exploratory Innovation
Novo Nordisk

Author:

John Mayfield

SVP BD & Strategy
Flagship Pioneering

John Mayfield

SVP BD & Strategy
Flagship Pioneering

Author:

Michaela Tolman

Commercial Development Lead for Inflammation & Immunology
Pfizer

Michaela Tolman

Commercial Development Lead for Inflammation & Immunology
Pfizer
Finalists

Author:

Adrian Grzybowski

Chief Scientific Officer
AnuBio

Adrian Grzybowski

Chief Scientific Officer
AnuBio

Author:

Rafael Carazo Salas

Founder & Chief Executive Officer
CellVoyant

Rafael Carazo Salas

Founder & Chief Executive Officer
CellVoyant

Author:

Kunal Jindal

Co-Founder & Chief Technology Officer
CapyBio

Kunal Jindal

Co-Founder & Chief Technology Officer
CapyBio

Author:

Daniel Haders, PhD

Chief Executive Officer & Founder
Model Medicines

Daniel Haders, PhD

Chief Executive Officer & Founder
Model Medicines
Time: 
9:45 AM - 10:45 AM
Session Type: 
General Session (Presentation)